<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03645109</url>
  </required_header>
  <id_info>
    <org_study_id>0240/18HCJIM/18</org_study_id>
    <nct_id>NCT03645109</nct_id>
  </id_info>
  <brief_title>Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus</brief_title>
  <official_title>Effect of Suplementation of 5,000 UI Vitamin D3 on the Glycemic Profile in Patients With Gestational Diabetes Mellitus of the Hospital Civil de Guadalajara Dr. Juan I. Menchaca</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eva Elizabet Camarena Pulido</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Civil Juan I. Menchaca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized double-blind placebo-controlled clinical trial. Consists of the administration of&#xD;
      5,000 IU of vitamin D3 vs Placebo in patients with gestational diabetes mellitus during eight&#xD;
      weeks. The objective is to analyze the effects of the intervention on the biochemical&#xD;
      parameters that are part of the glycemic profile (insuline, HBA1c, glucose)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two groups of patients diagnosed with gestational diabetes mellitus. Once the selection&#xD;
      criteria are verified, they will be assigned randomly in one of the two arms,one of them will&#xD;
      recive 5,000 IU of vitamin D and the other one placebo (talcum food grade). Baseline&#xD;
      measurements of vitamin D, glucose,insulin, HBA1c, calcium, phosphorus. At the end of the&#xD;
      eight weeks will be determined again the aforementioned biochemical parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 28, 2020</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel design, two arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The capsules with vitamin D or placebo have the same organoleptic characteristics. The jars and envelopes that contain them are identical. The envelopes are identified by a code that only knows who will analyze the data</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the parameters that make up the glycemic profile</measure>
    <time_frame>Eight weeks</time_frame>
    <description>Glucose, HBA1c, insuline,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in calcium, phosphorus and vitamin D3</measure>
    <time_frame>Eight weeks</time_frame>
    <description>Concentrations of calcium and phosphorus in blood and urine and vitamin D in blood</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Vitamin D3</condition>
  <condition>Gestational Diabetes Mellitus in Pregnancy</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive capsules with 5,000 IU of vitamin D3, one capsule orally once a day for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Will receive capsules with placebo (talcum food grade) one capsule orally once a day for eight weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Capsules with 5,000 IU of vitamin D3 once a day (one capsule)</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Capsules with placebo (talcum food grade)</intervention_name>
    <description>Capsules with placebo (talcum food grade)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients with a single pregnancy.&#xD;
&#xD;
          -  Patients diagnosed with GDM, which were diagnosed by a glucose tolerance curve 100&#xD;
             grams of glucose, with two altered results from the following: fasting&gt; 95 miligrams /&#xD;
             deciliter, 1 hour&gt; 180miligrams / deciliter, 2 hour&gt; 155miligrams / deciliter, 3hous&gt;&#xD;
             140 miligrams / deciliter.&#xD;
&#xD;
          -  Gestational age between 24 -30 weeks confirmed with ultrasound of the 1st or 2nd&#xD;
             trimester&#xD;
&#xD;
          -  Age between 18 and 40 years.&#xD;
&#xD;
        Exclusion Criteria: Patients with pre-existing diabetes mellitus&#xD;
&#xD;
          -  Patients with predictive factors for vitamin D hypovitaminosis such as: use of&#xD;
             anticonvulsants, renal disease, glomerular filtration rate &lt;60milliliters / minute,&#xD;
             thyroid disease or any other pre-existing endocrinological disorders.&#xD;
&#xD;
          -  Hypercalciuria&gt; 300 miligrams / day&#xD;
&#xD;
          -  Patients taking vitamin D supplementation during the 6 months prior to the study (does&#xD;
             not include polyvitamins with lower vitamin D concentrations &lt;500 IU)&#xD;
&#xD;
          -  Active and passive smoking patients.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salvador Mora</last_name>
    <role>Principal Investigator</role>
    <affiliation>OPD Hospital Civil de Guadalajara</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eva Elizabet Camarena Pulido</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44340</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011 Oct;26(10):2341-57. doi: 10.1002/jbmr.463. Erratum in: J Bone Miner Res. 2011 Dec; 26(12):3001.</citation>
    <PMID>21706518</PMID>
  </results_reference>
  <results_reference>
    <citation>Yu CK, Sykes L, Sethi M, Teoh TG, Robinson S. Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol (Oxf). 2009 May;70(5):685-90. doi: 10.1111/j.1365-2265.2008.03403.x. Epub 2008 Sep 2.</citation>
    <PMID>18771564</PMID>
  </results_reference>
  <results_reference>
    <citation>Parildar H, Dogruk Unal A, Aksan Desteli G, Cigerli O, Guvener Demirag N. Frequency of Vitamin D deficiency in pregnant diabetics at Baskent University Hospital, Istanbul. Pak J Med Sci. 2013 Jan;29(1):15-20. doi: 10.12669/pjms.291.2896.</citation>
    <PMID>24353500</PMID>
  </results_reference>
  <results_reference>
    <citation>Yazdchi R, Gargari BP, Asghari-Jafarabadi M, Sahhaf F. Effects of vitamin D supplementation on metabolic indices and hs-CRP levels in gestational diabetes mellitus patients: a randomized, double-blinded, placebo-controlled clinical trial. Nutr Res Pract. 2016 Jun;10(3):328-35. doi: 10.4162/nrp.2016.10.3.328. Epub 2016 May 16.</citation>
    <PMID>27247730</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 22, 2018</study_first_submitted>
  <study_first_submitted_qc>August 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Civil Juan I. Menchaca</investigator_affiliation>
    <investigator_full_name>Eva Elizabet Camarena Pulido</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

